Controlled trial of argon laser photocoagulation in bleeding peptic ulcers.
The efficacy of argon laser photocoagulation in the endoscopic control of haemorrhage from peptic ulcers was tested in a controlled trial at two centres in London. Of 330 patients consecutively admitted with acute upper gastrointestinal tract haemorrhage, 76 were seen at endoscopy to have a peptic ulcer accessible to laser therapy and stigmata of recent haemorrhage. These patients were included in the trial. Identification of the exact source of haemorrhage within the ulcer crater was achieved by use of standard endoscopes with careful washing. Patients were stratified into three groups: ulcers with a visible vessel (52 total, 11 actively spurting); those without a vessel (17); and those with an overlying clot persisting after washing (7). Of the 52 patients with visible vessel, 8 of 24 treated with the laser and 17 of 28 control patients had a further haemorrhage. 7 control patients died after an episode of rebleeding, but no treated patients. Treated and control patients were well matched for other factors known to influence the case fatality rate. This is the first controlled trial to demonstrate a significant reduction in mortality by the use of a non operative treatment in patients with bleeding peptic ulcers.
D000208:Acute Disease; D001128:Argon; D002986:Clinical Trials as Topic; D006801:Humans; D007258:Informed Consent; D053685:Laser Therapy; D007834:Lasers; D010438:Peptic Ulcer Hemorrhage / Q000401:mortality / Q000601:surgery*; D011897:Random Allocation; D012008:Recurrence
D001128:Argon